Related Experiment Video

Updated: Aug 25, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

The sum is greater than the FGFR1 partner

Benjamin S Braun1, Kevin Shannon

  • 1Department of Pediatrics and Comprehensive Cancer Center, University of California San Fransisco, San Francisco, CA 94143 USA.

Cancer Cell
|March 31, 2004
PubMed

Insights

Chromosomal translocations create fusion oncoproteins driving cancer. Researchers studied FGFR1 fusions in blood cancers, revealing their role in disease and potential as therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer-associated chromosomal translocations generate chimeric oncoproteins.
  • These oncoproteins contribute to aberrant cell growth through dominant or dominant-negative effects.
  • Genes like MLL, RARA, and EWS can fuse with multiple partners, influencing disease characteristics.

Purpose of the Study:

  • To investigate the role of specific chromosomal rearrangements in hematologic malignancies.
  • To analyze the functional impact of two distinct FGFR1 fusions.
  • To identify potential therapeutic targets based on these genetic alterations.

Main Methods:

  • Utilized a murine retroviral transduction/transplantation system.
  • Analyzed the pathogenesis of FGFR1 fusions in hematologic malignancies.
  • Examined the influence of partner genes on disease phenotypes.

Main Results:

  • Demonstrated that chromosomal rearrangements involving FGFR1 are central to the pathogenesis of hematologic malignancies.
  • Showcased how different partner genes modulate the specific disease phenotypes associated with FGFR1 fusions.
  • Identified potential therapeutic strategies targeting these specific genetic alterations.

Conclusions:

  • Chromosomal translocations creating FGFR1 fusions are key drivers in hematologic cancer development.
  • The choice of fusion partner significantly impacts the clinical and molecular features of the disease.
  • Understanding these fusions offers opportunities for developing targeted cancer therapies.

More Related Videos

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis10:43

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis

Published on: November 6, 2019

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...